PT643051E
(pt)
*
|
1992-09-30 |
2000-06-30 |
R Tech Ueno Ltd |
Processo de producao de cetonas alfa,beta-insaturadas
|
AU716005B2
(en)
|
1995-06-07 |
2000-02-17 |
Cook Medical Technologies Llc |
Implantable medical device
|
JP4358940B2
(ja)
*
|
1999-08-26 |
2009-11-04 |
丸善石油化学株式会社 |
シクロヘキサンラクトン構造を有する重合性化合物及び重合体
|
CA2307393A1
(en)
|
2000-05-01 |
2001-11-01 |
The University Of British Columbia |
Ginsenoside chemotherapy
|
US20030157170A1
(en)
*
|
2001-03-13 |
2003-08-21 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
WO2002072150A2
(en)
*
|
2001-03-13 |
2002-09-19 |
Angiotech Pharmaceuticals Inc. |
Micellar drug delivery vehicles and uses thereof
|
JP2004532847A
(ja)
*
|
2001-04-20 |
2004-10-28 |
ザ ユニヴァーシティ オヴ ブリティッシュ コロンビア |
疎水性薬物のためのミセル薬物送達システム
|
US20030216758A1
(en)
*
|
2001-12-28 |
2003-11-20 |
Angiotech Pharmaceuticals, Inc. |
Coated surgical patches
|
DE10220729A1
(de)
*
|
2002-05-08 |
2003-11-20 |
Martin Foerster |
Verfahren zum Bestimmen einer von Tieren gesoffenen Menge an flüssigen Nahrungsmitteln
|
US7351542B2
(en)
|
2002-05-20 |
2008-04-01 |
The Regents Of The University Of California |
Methods of modulating tubulin deacetylase activity
|
ATE457716T1
(de)
|
2002-12-30 |
2010-03-15 |
Angiotech Int Ag |
Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
|
CA2525647A1
(en)
|
2003-05-16 |
2005-02-24 |
Intermune, Inc. |
Synthetic chemokine receptor ligands and methods of use thereof
|
US7407973B2
(en)
*
|
2003-10-24 |
2008-08-05 |
Intermune, Inc. |
Use of pirfenidone in therapeutic regimens
|
US7846940B2
(en)
*
|
2004-03-31 |
2010-12-07 |
Cordis Corporation |
Solution formulations of sirolimus and its analogs for CAD treatment
|
US8003122B2
(en)
|
2004-03-31 |
2011-08-23 |
Cordis Corporation |
Device for local and/or regional delivery employing liquid formulations of therapeutic agents
|
US7989490B2
(en)
|
2004-06-02 |
2011-08-02 |
Cordis Corporation |
Injectable formulations of taxanes for cad treatment
|
AU2005273968A1
(en)
*
|
2004-08-09 |
2006-02-23 |
Alios Biopharma Inc. |
Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
|
US7597884B2
(en)
*
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
US20060188508A1
(en)
*
|
2005-02-17 |
2006-08-24 |
Cohen Stanley N |
Methods and compositions for modulating angiogenesis
|
US20070073385A1
(en)
*
|
2005-09-20 |
2007-03-29 |
Cook Incorporated |
Eluting, implantable medical device
|
CA2819844C
(en)
*
|
2006-02-07 |
2015-09-15 |
R-Tech Ueno, Ltd. |
Prostaglandin derivatives
|
AU2007228984B2
(en)
|
2006-03-22 |
2012-05-03 |
Syncore Biotechnology Co., Ltd |
Treatment of triple receptor negative breast cancer
|
ATE519511T1
(de)
|
2006-06-30 |
2011-08-15 |
Cook Inc |
Verfahren zur herstellung und modifizierung von taxan-beschichtungen für implantierbare medizinische vorrichtungen
|
US20080241215A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Robert Falotico |
Local vascular delivery of probucol alone or in combination with sirolimus to treat restenosis, vulnerable plaque, aaa and stroke
|
US8409601B2
(en)
*
|
2008-03-31 |
2013-04-02 |
Cordis Corporation |
Rapamycin coated expandable devices
|
US8420110B2
(en)
|
2008-03-31 |
2013-04-16 |
Cordis Corporation |
Drug coated expandable devices
|
US8273404B2
(en)
*
|
2008-05-19 |
2012-09-25 |
Cordis Corporation |
Extraction of solvents from drug containing polymer reservoirs
|
US9198893B2
(en)
|
2008-05-22 |
2015-12-01 |
Galera Labs, Llc |
Combination antitumor therapy
|
EP2310507A4
(de)
|
2008-07-08 |
2013-03-20 |
David Gladstone Inst |
Verfahren und zusammensetzungen zur angiogenesemodulierung
|
US8642063B2
(en)
|
2008-08-22 |
2014-02-04 |
Cook Medical Technologies Llc |
Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
|
US8513441B2
(en)
*
|
2008-08-29 |
2013-08-20 |
Alphora Research Inc. |
Prostaglandin synthesis and intermediates for use therein
|
ES2477552T3
(es)
|
2008-09-08 |
2014-07-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Moduladores de la actividad de la aldehidodeshidrogenasa y métodos de uso de los mismos
|
US9198968B2
(en)
|
2008-09-15 |
2015-12-01 |
The Spectranetics Corporation |
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
|
WO2010062308A1
(en)
|
2008-10-28 |
2010-06-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulators of aldehyde dehydrogenase and methods of use thereof
|
WO2010083597A1
(en)
|
2009-01-22 |
2010-07-29 |
Apotex Pharmachem Inc. |
Methods of making lubiprostone and intermediates thereof
|
US10457659B2
(en)
|
2011-04-29 |
2019-10-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for increasing proliferation of adult salivary stem cells
|
US20120302954A1
(en)
|
2011-05-25 |
2012-11-29 |
Zhao Jonathon Z |
Expandable devices coated with a paclitaxel composition
|
US20120303115A1
(en)
|
2011-05-25 |
2012-11-29 |
Dadino Ronald C |
Expandable devices coated with a rapamycin composition
|
US9956385B2
(en)
|
2012-06-28 |
2018-05-01 |
The Spectranetics Corporation |
Post-processing of a medical device to control morphology and mechanical properties
|
AU2013290424B2
(en)
|
2012-07-19 |
2018-01-25 |
Redwood Bioscience, Inc. |
Antibody specific for CD22 and methods of use thereof
|
EP2916835A4
(de)
|
2012-11-12 |
2016-07-27 |
Redwood Bioscience Inc |
Verbindungen und verfahren zur herstellung eines konjugats
|
PT2956175T
(pt)
|
2013-02-15 |
2017-12-26 |
Univ California |
Recetor de antigénio quimérico e métodos de utilização do mesmo
|
EP2970124B1
(de)
|
2013-03-14 |
2019-05-22 |
The Board of Trustees of the Leland Stanford Junior University |
Mitochondriale aldehyd-dehydrogenase-2-modulatoren und verfahren zur verwendung davon
|
US9493413B2
(en)
|
2013-11-27 |
2016-11-15 |
Redwood Bioscience, Inc. |
Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
|
PL3107899T3
(pl)
|
2014-02-19 |
2021-01-25 |
Aviv Therapeutics, Inc. |
Policykliczne amidy wiążące mitochondrialną dehydrogenazę aldehydową-2 (aldh2) i ich zastosowanie w leczeniu nowotworów
|
JP6877049B2
(ja)
|
2015-09-25 |
2021-05-26 |
ゼットワイ セラピューティクス インク.Zy Therapeutics Inc. |
多糖類−ビタミン共役体を含む粒状物に基づく薬物製剤
|
EP3373977A4
(de)
|
2015-11-12 |
2019-07-17 |
The Board of Trustees of the Leland Stanford Junior University |
Zellenpenetrierende, guanidiniumreiche oligophosphotriester zur wirkstoff- und sondenfreisetzung
|
TWI760319B
(zh)
|
2015-12-30 |
2022-04-11 |
杏國新藥股份有限公司 |
乳癌治療
|
US11208632B2
(en)
|
2016-04-26 |
2021-12-28 |
R.P. Scherer Technologies, Llc |
Antibody conjugates and methods of making and using the same
|
JP7109427B2
(ja)
|
2016-06-01 |
2022-07-29 |
セルヴィエ アイピー ユーケー リミテッド |
ポリアルキレンオキシド-アスパラギナーゼの製剤ならびにその製造法および使用法
|
MX2019008503A
(es)
|
2017-01-18 |
2019-09-13 |
F1 Oncology Inc |
Receptores de antigenos quimericos contra axl o ror2 y metodos de uso de los mismos.
|
EP3388082A1
(de)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Kombinationskrebsimmuntherapie mit makrocyclischem pentaaza-ringkomplex
|
CA3090129A1
(en)
|
2018-01-31 |
2019-08-08 |
Galera Labs, Llc |
Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent
|
US11660266B2
(en)
|
2018-04-11 |
2023-05-30 |
Ohio State Innovation Foundation |
Methods and compositions for sustained release microparticles for ocular drug delivery
|
JP2021530507A
(ja)
|
2018-07-18 |
2021-11-11 |
マンザニータ ファーマシューティカルズ,インク. |
神経細胞に抗がん剤を送達するためのコンジュゲート、その使用方法及び製造方法
|
WO2020148612A1
(en)
|
2019-01-14 |
2020-07-23 |
Ignite Immunotherapy, Inc. |
Recombinant vaccinia virus and methods of use thereof
|
JP2022520220A
(ja)
|
2019-02-14 |
2022-03-29 |
イグナイト イミュノセラピー インク |
組換えワクシニアウイルスおよびその使用方法
|
WO2020206033A1
(en)
|
2019-04-02 |
2020-10-08 |
Kenjockety Biotechnology, Inc. |
Efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
|
BR112022011158A2
(pt)
|
2019-12-12 |
2022-08-30 |
Ignite Immunotherapy Inc |
Vírus vaccinia oncolítico variante e métodos de uso do mesmo
|
CA3164608A1
(en)
|
2020-01-29 |
2021-08-05 |
Kenjockety Biotechnology, Inc. |
Anti-mdr1 antibodies and uses thereof
|
AU2021283080A1
(en)
|
2020-06-04 |
2022-12-15 |
Kenjockety Biotechnology, Inc. |
ABCG2 efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
|
WO2021247426A1
(en)
|
2020-06-04 |
2021-12-09 |
Kenjockety Biotechnology, Inc. |
Anti-abcg2 antibodies and uses thereof
|
EP4182335A2
(de)
|
2020-07-14 |
2023-05-24 |
Pfizer Inc. |
Rekombinantes vacciniavirus
|
KR20230061429A
(ko)
|
2020-09-02 |
2023-05-08 |
켄조케티 바이오테크놀러지 인코포레이티드 |
항-abcc1 항체 및 이의 용도
|
US20240010747A1
(en)
|
2020-11-13 |
2024-01-11 |
Kenjockety Biotechnology, Inc. |
Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
|
WO2023114658A1
(en)
|
2021-12-13 |
2023-06-22 |
Kenjockety Biotechnology, Inc. |
Anti-abcb1 antibodies
|
WO2023159220A1
(en)
|
2022-02-18 |
2023-08-24 |
Kenjockety Biotechnology, Inc. |
Anti-cd47 antibodies
|